Automobile Product liability Attorney Wanted:


Pro-Per draft complaint beloW

For your firm or legal assistance consideration outlines my claims to FCA Chrysler denial in resolution attempts:



IN THE SUPERIOR COURT OF THE STATE OF ARIZONA
IN AND FOR THE COUNTY OF MARICOPA
  • Case No.: [Case Number]

  • Plaintiff: Emory Caudill
    Defendants: FCA US LLC f/k/a Chrysler LLC, a Delaware limited liability company, Larry Miller Jeep Chrysler Dodge and Grammer Industries, Inc.

  • COMPLAINT FOR PRODUCT LIABILITY AND REQUEST FOR JURY TRIAL

    Preliminary Statement
    This action arises from the Plaintiff, Emory Caudill, sustaining severe physical and psychological injuries due to the unexpected deployment of a defective Active Head Restraint (AHR) system manufactured and distributed by the Defendants, FCA US LLC and Grammer Industries, Inc. The Plaintiff brings this suit not only to seek redress for his injuries but also to highlight a significant public safety threat posed by the Defendants' defective AHR systems.

    Arizona's elderly drivers, veterans suffering from post-traumatic stress disorder (PTSD), previous traumatic brain injury, and individuals with pre-existing spinal conditions are particularly vulnerable to the harms caused by these defects both as drivers and passengers. The Defendants' knowledge of the AHR system's propensity for unintended deployment and their failure to act responsibly necessitate intervention to protect Arizona's residents.

    The Plaintiff respectfully requests this Court to address the Defendants' negligence and to consider the broader implications for public safety, including recommending intervention by the Arizona Attorney General to prevent further harm to vulnerable populations within the state.

    Despite the severity of the injuries sustained and the Defendant's history of product defects, particularly concerning Active Head Restraint systems, the Plaintiff has encountered significant challenges in securing legal representation. The Defendant's extensive legal resources and the high costs associated with litigation have compelled the Plaintiff to proceed pro se. This disparity underscores the necessity for intervention by the Arizona Attorney General to ensure a fair and just resolution, not only for the Plaintiff but also for other Arizona residents facing similar obstacles in holding large corporations accountable.

  • I. Jurisdiction and Venue

  • This Court has jurisdiction and venue under Arizona law because the events giving rise to this action occurred in Arizona, the Plaintiff resides in Maricopa County, and the Defendants conduct business within the State.

    This Court is the most appropriate venue for this action, as the Plaintiff’s claims arise from injuries sustained in Arizona Plaintiff’s economic damages are intricately tied to Arizona’s state-regulated cannabis industry, which is governed by Arizona law. Plaintiff’s economic and physical injuries have also directly impacted Arizona’s Medicaid system. Furthermore, Arizona courts are uniquely qualified to address state-specific considerations, including Plaintiff’s projected financial losses tied to his licensed role in Arizona’s medical cannabis framework

  • II. Parties

  • Plaintiff, Emory B. Caudill III, is a resident of Maricopa County, Arizona

  • Defendant FCA US LLC, formerly known as Chrysler LLC, is a Delaware limited liability company that, at all times relevant to this complaint, manufactured, distributed, and sold products, including the product at issue, in Arizona

  • Defendant Grammer Industries, Inc., a South Carolina corporation, manufactured and supplied components of the defective Active Head Restraint (AHR) system for use in vehicles sold in Arizona, including the Plaintiff’s..

  • III. Factual Allegations


  • Despite having a pre-existing lumbar spine condition with a surgical cage from approximately 2 decades ago and neck arthritis diagnosed several years ago, the Plaintiff had not experienced any acute neck symptoms or required treatment for the condition in the years leading up to the AHR deployment, of which Primary care medical records will evidence. This demonstrates that the Plaintiff’s conditions were not actively symptomatic at the time of the incident.

  • The startling and unexpected deployment of the AHR caused the Plaintiff to experience an instinctive self-defense reaction, resulting in a sudden twisting motion to fight a perceived attack behind him. This reaction led to an immediate onset of severe pain and sciatica in the lumbar region, as later documented during medical evaluations. While the lower back injury aggravation was specifically attributable to the startling effect of the deployment, the hyperflexion caused by the AHR deployment directly aggravated the Plaintiff’s pre-existing neck arthritis, which was further compounded by the fight-or-flight response.


  •    

  • Incident and Initial Trauma Response

  •  On July 7, 2023, after dark, Plaintiff entered the driver’s side of his 2017 Jeep Patriot and closed the door using his usual method due to limitations from prior shoulder surgeries from early 1990’s. While his head was positioned at a rearward angle, the Active Head Restraint (AHR) system unexpectedly deployed, creating a loud noise and impact without any external collision or airbag warning.

  • Consequently, Plaintiff’s head moved backward at a left facing angle, similar to the position the driver would assume when looking into the driver side mirror if the door were closed. At that moment, the Active Head Restraint (AHR) system unexpectedly deployed, seemingly in sync with the door slamming shut, and without any external impact or rear collision event, nor was the dashboard SRS airbag deployment warning light triggered from the AHR system tied to the SRS airbag control system before or after it randomly deployed. Plaintiff’s head was in extremely close proximity to the device, a replacement for the standard headrest, which he and his wife had believed the standard device was purchased with the vehicle. The AHR, known to the manufacturer for over a decade to deploy randomly under certain conditions, engaged without warning.

  • The unexpected deployment triggered a startle response, causing Plaintiff to perceive an imminent physical threat behind him. This reaction led to violent twisting despite his pre-existing spinal condition, resulting in severe injuries, including a traumatic brain injury (TBI), spinal trauma, and post-traumatic stress disorder (PTSD)

  • The Costa v. FCA U.S. LLC case provides expert testimony confirming that AHR deployment can produce a startle response, which may cause immediate distraction and create a sense of danger. The intense startle effect of this AHR deployment led Plaintiff to perceive an imminent threat, triggering post-traumatic stress disorder (PTSD) symptoms, including heightened vigilance and recurrent fears of being attacked. As a result of AHR random deployment other serious injuries were sustained to include Concussion, traumatic brain injury, and spinal injuries.

    The deployment of the AHR triggered severe emotional and psychological trauma The Plaintiff was diagnosed with PTSD, marked by recurring fears of being attacked, anxiety, depression, and hyper-vigilance. The incident caused significant distress, exacerbated by the stress of quitting cigarettes to prepare for necessary surgery, adding to the Plaintiff's ongoing mental anguish.

  • Efforts to Seek Timely Care and Chrysler’s Refusal to Assist

  • Following the injuries sustained from the unexpected deployment of the defective Active Head Restraint (AHR) system, the Plaintiff made concerted efforts to seek timely medical treatment. Recognizing the urgency of addressing his injuries and his inability to afford necessary care, the Plaintiff reached out directly to Chrysler at its highest levels, including communications with the company’s Senior Attorney via its representative, Michelle.

  • During these discussions, the Plaintiff explicitly requested financial assistance from Chrysler to cover alternative medical treatments that were urgently needed but unaffordable due to systemic healthcare denials. Despite being aware of the severity of the injuries caused by the defective AHR system and acknowledging the defect itself, Chrysler refused to provide any meaningful assistance. Instead, Chrysler offered a nominal $2,500 "donation," which the Plaintiff declined, as it was insufficient to cover even basic medical expenses and failed to address the Plaintiff’s suffering.

  • Chrysler’s refusal to act exacerbated the Plaintiff’s injuries by delaying necessary care and added to the physical, emotional, and financial toll caused by their defective product. This inaction further underscores the Defendant’s disregard for consumer safety and well-being.

  •  

  • Impact on Pre-Existing Conditions and Resulting Injuries
    Prior to the AHR deployment on July 7, 2023, the Plaintiff had not required or sought medical attention for significant lower back complaints for an extended period, reflecting stability in his pre-existing lumbar condition.
    Medical records demonstrate a gap in treatment for lumbar issues, which suggests that the Plaintiff's condition had been manageable and stable prior to the incident.
       
    The AHR deployment triggered a sudden and violent twisting motion as the Plaintiff instinctively reacted to a perceived life-threatening attack. This motion significantly aggravated the Plaintiff’s pre-existing lumbar spine condition, resulting in new symptoms, including severe lower back pain, sciatica, and intermittent weakness radiating from the buttocks and thighs.
       

  • The Plaintiff’s medical records indicate that these new and worsening symptoms emerged immediately following the AHR deployment and were absent during prior evaluations, highlighting a causal link to the incident.
       

  •  

  • The Plaintiff’s injuries from the AHR deployment significantly aggravated pre-existing conditions, including degenerative disc disease and congenital spinal stenosis. The incident caused a rapid worsening of these conditions, leading to partial paralysis in the left leg and foot, urinary incontinence, and severe pain. Medical records document a steady decline in the Plaintiff’s condition until a three-level neck fusion surgery was performed in April 2024. This decline was directly attributable to the AHR deployment.

  • Additionally, the Plaintiff experienced a worsening of his lumbar spine condition, requiring epidural injections to manage severe symptoms. These injuries represent a direct and compensable consequence of the Defendants’ defective product under Arizona’s legal standards.

    Aggravation and Worsening of Pre-Existing Cervical Injuries

  • The Plaintiff sustained significant cervical injuries resulting from the unexpected deployment of the defective Active Head Restraint (AHR) system. The injury mechanism involved both:

  • 1.      An initial hyperflexion injury caused by the AHR deployment, which worsened pre-existing cervical spine degeneration.

  • 2.      A secondary injury from a fight-or-flight response, as the Plaintiff twisted violently in reaction to the startling event.

  • Supporting Evidence

  • ·         Imaging prior to the incident (August 2023 MRI Exhibit D) documented chronic degeneration of C4-C7 with moderate to severe spinal canal stenosis and foraminal narrowing without active neurological symptoms requiring treatment​

  • Following the AHR deployment, the Plaintiff underwent a three-level anterior cervical discectomy and fusion (ACDF) from C4-C7 in April 2024 to address worsening spinal canal and foraminal stenosis, as revealed by post-surgical CT imaging​. (Post_Fusion_CT.pdf exhibit B)

  • The November 2024 MRI further evidenced new and progressive changes at C3-C4, including a 0.69 cm central disc bulge, moderate facet overgrowth, and mild spinal stenosis, which likely resulted from altered spinal biomechanics after the trauma and surgery​. (Nov24_Cervical.pdf Exhibit C)

  •  

  • Impact on Plaintiff’s Career and Economic Losses

  • At the time of the incident, Plaintiff was actively working to transition off Social Security Disability and was engaged in developing a business venture within Arizona’s state-licensed medical cannabis industry. Plaintiff was the inventor of a process for which he was licensed to present and develop under Arizona law. Plaintiff’s work and credibility in this field were supported by his background as a long-time advocate for medical marijuana (MMJ) and his role as the former elected State Deputy Director of NORML. Plaintiff had engaged high-profile attorneys within Arizona to support his business endeavors and had secured a distribution agreement with a leading cannabis distributor in Arizona, guaranteeing the sale of any amount legally produced under state law, produced using Plaintiff’s process. Plaintiff’s injuries caused by the defective AHR system directly impaired his ability to complete this business endeavor, resulting in substantial financial losses.

  • FCA’s Pattern of Unfair Practices and Current Probation

  • In Costa v. FCA, a jury found FCA guilty of engaging in unfair acts or practices against consumers, despite FCA avoiding a recall by extending the warranty for affected Active Head Restraint (AHR) systems. This pattern of behavior demonstrates a systemic disregard for consumer safety and fairness.

  • Furthermore, FCA is currently under criminal probation for the second time, underscoring the company’s ongoing pattern of unethical and potentially unlawful conduct. FCA’s corporate actions reflect a broader failure to prioritize safety and accountability, placing consumers at continued risk of harm.

  • FCA’s conduct in addressing consumer claims, including the Plaintiff’s, further demonstrates this pattern of unfair and deceptive practices. During recorded calls before Christmas 2023, a representative of FCA’s Senior Attorney admitted that FCA was aware of the defect, stating that “there is a problem” and that their engineers were “working on it.” In the Plaintiff’s diminished mental state, he reasonably interpreted this statement to mean that FCA intended to issue a recall or implement preventive measures. As a result, the Plaintiff offered to sign a non-disclosure agreement (NDA) upon reaching a settlement and committed to speaking highly of FCA for taking responsible action.

  • The Plaintiff had advocated for mitigation strategies after his injury and subsequent research of others claiming injury, including the adoption of safety protocols from the aviation industry, to address the risks posed by millions of aging vehicles potentially affected by the defect, as referenced in Costa v. FC Despite acknowledging the defect, FCA offered the Plaintiff a nominal $2,500 “donation,” framing it as a gesture of sympathy rather than a legitimate settlement. This offer was conditioned on the Plaintiff signing the ND The representative also mentioned replacing the defective AHR system with a “fresh one,” which the Plaintiff later discovered referred to a post-August 2017 AHR model redesigned to address the risks of unintended deployment.

  • This approach—privately acknowledging the defect while minimizing the severity of individual claims—illustrates FCA’s strategy to limit liability and avoid public accountability. By framing the Plaintiff’s injuries as minor and offering insufficient remedies, FCA’s conduct reflects a broader corporate strategy of misleading and dismissive practices that prioritize limiting liability over consumer safety.



  •  

  • FCA’s Early Knowledge of the AHR Defect:

  • FCA has long been aware of defects in the AHR system. Internal documents and expert testimony in Costa v. FCA U.S. LLC revealed that FCA knew as early as 2009 of the AHR system’s tendency for unintentional deployment, with reports of injuries dating back to 2011

  • By 2013, FCA had received numerous reports of injuries, including whiplash and soreness, linked directly to AHR malfunctions, highlighting foreseeable risks. .  Even if the rate of unintended AHR deployments is statistically low, the risks were entirely foreseeable and preventable. FCA’s own testing, warranty claims, and consumer complaints revealed a pattern of failures tied to the spring-loaded mechanism. Despite this knowledge, FCA failed to redesign the product or adequately warn consumers of the risks, prioritizing cost savings over safety. Despite this knowledge, FCA continued selling vehicles with the defective AHR systems without adequately informing consumers. (Costa Opinion for cert)

  • Selective Outreach

  • FCA Chrysler’s selective outreach to individual consumers further demonstrates their failure to protect the broader public. For example, a Chrysler representative contacted the Plaintiff’s wife directly using dealership records, showing they had the means to inform all vehicle owners of potential risks. Despite this capability, FCA failed to issue widespread warnings or recalls, leaving most consumers unaware of the dangers posed by defective AHR systems.

  • As detailed in the Public Policy and Consumer Protection Concerns section, the Defendant's actions have broader implications for public safety and consumer rights. Despite being aware of the risks associated with the AHR system since 2009, FCA failed to notify all affected consumers, even though they had the means to do so through dealership records and customer contact information. For example, FCA’s representative Michelle was able to contact the Plaintiff’s wife directly apparently using information provided at the time of vehicle purchase. This demonstrates that FCA possessed the ability to notify consumers about AHR deployment risks but chose not to act, leaving the vast majority of owners uninformed about the dangers posed by their vehicles.

  •  

  • FCA’s Pattern of Unfair Practices and Consumer Challenges.

  • Despite significant documented defects and consumer reports of injuries caused by the AHR system, FCA Chrysler has demonstrated a consistent pattern of prioritizing cost savings over consumer safety. This pattern was highlighted in Costa v. FCA, where a jury found FCA guilty of engaging in unfair acts or practices against consumers.

  • Moreover, the high costs associated with pursuing claims against FCA Chrysler have created substantial barriers for individuals seeking justice. Plaintiff has faced significant challenges securing legal representation for this matter, a reality that underscores the imbalance of resources between injured consumers and corporate defendants.

  • FCA’s Dismissive Responses to Consumer Claims

  • During recorded calls before Christmas of 2023, a Chrysler representative, identifying herself as subordinate to the Senior Attorney, contacted the Plaintiff and his wife regarding the injuries caused by the deployment of the Active Head Restraint (AHR) system. Over the course of several weeks, the representative made multiple calls, and during the final call, she offered what she described as a $2,500 “donation” from the Senior Attorney, stating it was offered “because they felt sorry for” the Plaintiff. The phrasing and nominal amount of this offer, delivered hesitantly, conveyed a dismissive attitude toward the severity of the Plaintiff’s injuries. Additionally, the timing and context of this offer implied a potential response to the Plaintiff’s public advocacy regarding AHR defects, including statements made on the Top Class Action website and other forums. This conduct reflects FCA Chrysler’s pattern of minimizing individual claims to avoid broader accountability for their defective product and the resulting harm.

  • The offer of a $2,500 “donation,” presented after the holiday season of 2023, further exacerbated the emotional toll on the Plaintiff and his wife. Prior to Christmas, the representative conveyed uplifting and sympathetic messages, such as assuring them not to worry, expressing sorrow, and offering to help in any way possible. These communications gave the Plaintiff and his wife hope for a fair settlement resolution in the new year. However, the nominal amount of the post-holiday offer—framed as a gesture of sympathy—underscored FCA’s dismissive attitude toward the severity of the Plaintiff’s injuries and economic losses. The timing of this offer, coupled with the Plaintiff’s financial hardships leading into the holiday season and their unmet expectations of resolution, left the Plaintiff and his wife feeling betrayed by a company they had trusted. This emotional harm is directly attributable to FCA’s failure to meaningfully address the consequences of their defective product.

  •  

  • FCA’s Response to Known Defects

  • In August 2017, FCA began washing AHR striker pins with alcohol to remove an oil contaminant claimed by FCA and Grammer AG of causing environmental stress cracking (ESC) in the plastic sled by chemical reaction, leading to unintentional AHR deployment. FCA’s action suggests that it was aware of this issue but failed to implement adequate safety measures in vehicles already on the market, including the Plaintiff’s vehicle, purchased on December 31, 2016. (Costa Opinion for cert) 

  •  

  • Despite making some efforts to mitigate known issues, such as washing internal AHR components with alcohol, FCA failed to address the fundamental risks inherent in the AHR design, including the potential for unintended deployment and associated injuries. These foreseeable risks highlight the availability of safer, non-active alternatives, as detailed below.

  • Foreseeable Risks and Safer Non-Active Alternatives


  • Defendants were aware of the risks posed by the AHR system’s spring-loaded mechanism, including its potential for unintended deployment. These risks were foreseeable given internal testing failures, warranty claims, and consumer complaints spanning over a decade, as revealed in Costa v. FCA U.S. LLC. Despite this knowledge, Defendants failed to implement design changes to mitigate these hazards.

  • Safer alternatives were available at the time of the AHR system’s development, including non-active systems like Volvo’s Whiplash Protection System (WHIPS). WHIPS achieves effective whiplash protection through a fixed design that integrates the headrest with the seatback to absorb collision energy without requiring moving parts or active deployment mechanisms. Studies demonstrate that WHIPS reduced neck injury claim rates by 49% compared to earlier Volvo models. By eliminating moving parts, non-active systems like WHIPS entirely remove the risk of unintended deployment while achieving the intended safety objectives.

  • In contrast, the Grammer AG AHR system has faced scrutiny for unintended deployments, including class action lawsuits alleging injuries such as head and neck injuries. Additionally, news reports from various states have highlighted numerous incidents of concussions facial, hand laceration and treatments for anxiety claims from random and unexpected AHR deployments, further underscoring the risks associated with the design.

  • The risk of such injuries is exacerbated by the instructions provided in Defendants' owner’s manuals. Manuals describe how to adjust the AHR by pulling or pushing the device, yet fail to warn users of the potential deployments during adjustments. Defendants’ own manuals vaguely caution that body parts, such as a hand, could “accidentally” trigger deployment and cause injury. Despite this warning, the manuals do not provide clear guidance on avoiding injury or ensuring safe handling, nor do they distinguish between standard headrests and the more sensitive AHR mechanism.

  • This contradictory messaging—claiming a “virtually zero chance of harm” from a random AHR deployment while simultaneously warning of potential deployment and injury from “accidental” contact—further demonstrates the inherent instability of the design. The likelihood of injuries such as hand and facial lacerations during routine adjustments or accidental contact is foreseeable and preventable, had Defendants implemented a safer and more stable design.

  • The absence of clear labeling identifying the AHR system as an active, spring-loaded mechanism exacerbated the foreseeable risks of accidental deployment. Without proper labeling, Plaintiff was unaware that a rapidly deploying device capable of triggering a startle response was positioned directly behind his head. This lack of labeling, coupled with Defendants’ failure to warn of the dangers, directly contributed to Plaintiff’s perception of an imminent attack when the device deployed unexpectedly. This startling effect caused Plaintiff to experience a fight-or-flight response, resulting in PTSD and ongoing psychological trauma

  •  

  • IV. Failure to Adopt Safer Alternative Design

  •           Safer Design Alternatives Were Feasible

  • Defendants were aware of the risks posed by the AHR system’s spring-loaded mechanism, including the potential for unintended deployment. These risks were foreseeable based on internal testing failures, warranty claims, and consumer complaints spanning over a decade, as revealed in Costa v. FCA U.S. LLC.

  • Safer and cost-effective alternatives were available at the time of the AHR system’s development. These alternatives could have eliminated the risk of unintended deployment while achieving the intended safety function of mitigating whiplash in rear-end collisions.

  • 1.      Non-Active Systems
    Examples of safer alternatives include non-active systems like Volvo’s Whiplash Protection System (WHIPS). This system integrates the headrest with the seatback to absorb collision energy without requiring moving parts or active deployment mechanisms. Studies have shown WHIPS reduced neck injury claims by 49% compared to earlier Volvo models.

  • 2.      Permanently Extended Headrests
    The AHR system was intended to “catch” the occupant’s head by supporting and slowing rearward momentum during a collision, similar to how a parachute slows a dragster’s speed.  A permanently extended headrest with rearward spring protection could have achieved the same whiplash protection goals without the need for spring-loaded mechanisms. This design avoids the inherent risks of unexpected activation and simplifies manufacturing.

  • 3.      Enhanced Testing Protocols
    Industry-standard crash testing protocols, such as those conducted by the Insurance Institute for Highway Safety (IIHS), position crash test dummies heads sufficient distance away from the pre deployed AHR to prevent head contact until after it has fully deployed. This deployment is so fast after the rear end impact trigger is activated the full deployment occurs before the advancing shock wave has any effect upon the heads movement. This suggests that the design was not intended for the AHR to launch the head forward but to initiate contact with the occupant’s head, by catching it from close proximity.

  • Foreseeable risks, including those from accidental deployments during routine adjustments, were entirely preventable had Defendants implemented a non-active design or provided clear warnings about the heightened sensitivity of the AHR mechanism.

  • User Confusion and Lack of Distinguishable Markings

  • As stated in some users manuals and omitted in others, the AHR  system contains no distinguishable markings or warnings that it is an AHR vs the standard headrest, creating confusion among users. Vehicle user manuals issued by Defendants further exacerbate this confusion by combining instructions for adjusting both standard headrests and the AHR. For example, manuals direct users to adjust the headrest by pulling it up or down but fail to warn that these actions could inadvertently trigger deployment. This omission exposes consumers to significant risks, as accidental deployment while handling the AHR can cause injury.

  • This lack of clarity in design and instructions would likely lead to more numerous reports of injuries from accidental deployments, highlighting the real-world consequences of Defendants’ inadequate warnings and flawed design choices. Reports of injuries in news media include facial and hand lacerations caused by accidental AHR deployment, which underscores the potential danger posed by vague or misleading guidance. Defendants' contradictory messaging—simultaneously claiming "virtually zero chance of harm" while cautioning about the potential for accidental deployment and injury—demonstrates their awareness of the risks. These warnings underscore the foreseeability of harm, contradicting any assertion that such risks were insignificant or unforeseeable.

  • The absence of clear warnings or labeling about AHR mechanisms fails to adequately inform consumers about the heightened risks associated with their use, violating reasonable consumer safety expectations. These foreseeable risks were entirely preventable had Defendants implemented a safer and more stable design or provided clear and consistent warnings within sight of occupants.

  • Public Awareness Deficiencies and Need for Consumer Education

  • Despite the Defendants’ knowledge of the risks associated with the Active Head Restraint (AHR) system, they failed to adequately warn consumers or provide sufficient information to identify the device or its potential for unintended deployment. This failure has resulted in a widespread lack of awareness among vehicle owners about the presence and dangers of the AHR system.

  • Since the incident on July 7, 2023, Plaintiff and his wife have spoken with numerous drivers of vehicles equipped with AHR systems, including individuals in parking lots, store lines, and delivery personnel. With the exception of one individual, none were aware of the device’s existence or the risks it poses. This suggests that Defendants’ omissions have left the vast majority of consumers uninformed and unprepared for potential malfunctions.

  • Plaintiff respectfully submits that independent polling or consumer surveys could substantiate the claim that consumers remain largely unaware of the dangers associated with AHR systems. Such data would support the assertion that Defendants failed in their duty to warn and educate the public, as required under applicable consumer protection and product liability laws.



  • Defendants Prioritized Cost Over Safety

  • Despite knowing of these safer alternatives, Defendants opted for a spring-loaded design that increased the likelihood of injury. The decision to use this design was driven by cost considerations, as implementing a fixed headrest or adopting alternative technologies would have required upfront investment. Defendants’ prioritization of cost savings over consumer safety demonstrates negligence and a disregard for foreseeable risks.

  • Testing Revealed AHR Deployment Risks

  • Defendants’ internal testing revealed the inherent instability of the AHR system’s spring-loaded design. These tests showed:

  • The AHR system could deploy unintentionally under environmental stress or minor vibrations.

  • The plastic sled components were prone to environmental stress cracking (ESC), exacerbated by exposure to certain oils and contaminants.

  • Dummy testing placed heads at a distance from the AHR during deployment, but real-world use does not guarantee this positioning, leading to increased risks of head injuries.

  • Contradictory Messaging in Consumer Manuals

  • Defendants compounded these risks by failing to provide adequate warnings or distinguishing markings in their user manuals. For example:

  • Manuals instructed users to adjust the AHR system by pulling or pushing the device but did not warn of potential accidental deployment.

  • Warnings that body parts could "accidentally" trigger deployment were insufficiently prominent and contradicted claims of a "virtually zero chance of harm."

  • This lack of clear communication about the AHR system’s heightened sensitivity exposed consumers to avoidable risks. Proper labeling or instructions could have mitigated these hazards.

  •  

  •  

  • Public Policy and Consumer Protection Concerns

  •  Public Safety Concerns for Vulnerable Populations

  • The Defendant's defective Active Head Restraint (AHR) systems pose significant risks to vulnerable groups, including elderly drivers, veterans with PTSD, and individuals with pre-existing spinal conditions. Studies indicate that a substantial percentage of elderly individuals suffer from degenerative disc disease or spinal stenosis, conditions that can be exacerbated by sudden trauma such as unexpected AHR deployment. Similarly, veterans with PTSD or prior concussions are at increased risk of severe psychological and physical harm from such incidents. The Defendant's failure to address these known defects endangers these populations, highlighting a pressing public safety concern.

  •  

  • B. Challenges Faced by Pro Se Litigants

  • The Plaintiff's pro se status underscores the systemic challenges that individual consumers face when seeking justice against large corporations with extensive legal and financial resources. This significant imbalance often deters individuals from pursuing valid claims, allowing negligent practices to persist unchecked. The Plaintiff's inability to secure legal representation, despite the severity of the injuries sustained, exemplifies the barriers to justice that many consumers encounter. Intervention by the Arizona Attorney General is essential to address these disparities, protect public safety, and ensure that all Arizona residents have equitable access to justice, regardless of their financial means or legal representation.

  • C. Failure to Notify Consumers
    FCA’s selective outreach to individual claimants highlights a systemic failure to notify consumers about known defects in the AHR system. Despite possessing customer contact information, FCA did not issue widespread warnings or recalls to inform vehicle owners of the potential dangers. For example, a Chrysler representative contacted the Plaintiff’s wife directly, apparently using dealership records from the vehicle’s purchase. This demonstrates that FCA had the capability to notify consumers but chose not to act, leaving the vast majority of owners uninformed about the dangers posed by their vehicles. This omission not only endangers public safety but also reflects a disregard for consumer rights and transparency. The Arizona Attorney General’s office is uniquely positioned to investigate FCA’s notification practices and hold the company accountable for its failure to protect Arizona residents from preventable harm.

  • Broader Implications
    FCA’s selective outreach and failure to notify the broader consumer base about the risks associated with defective AHR systems reflect a systemic disregard for public safety. Despite having access to dealership records and the ability to contact consumers directly, FCA chose not to issue widespread warnings or recalls, leaving countless drivers and passengers at risk.

  • This omission is particularly egregious given that many vehicles are sold used or without manuals, leaving subsequent owners and passengers unaware of potential hazards. Additionally, the lack of visible markings or warnings on AHR systems exacerbates the danger, as drivers and passengers may inadvertently rest their heads on the AHRs without realizing the associated risks.

  • FCA’s failure to act demonstrates the urgent need for systemic changes, including mandatory notifications, improved labeling, and enhanced consumer education to mitigate the risks posed by defective AHR systems.

  •  

  •  

  • V. Causes of Action

  • Count 1: Strict Product Liability

  • Defendants are strictly liable for the physical injuries and lasting harm sustained by the Plaintiff due to the defective and unreasonably dangerous design and manufacture of the Active Head Restraint (AHR) system. Under the eggshell skull doctrine, Defendants are fully liable for the Plaintiff’s injuries, including those aggravated by pre-existing conditions. This doctrine ensures that a Defendant must compensate a Plaintiff for the full extent of injuries caused by their negligence, regardless of the Plaintiff's pre-existing vulnerabilities.

  • The Defendants are strictly liable for the injuries sustained by the Plaintiff due to the defective AHR system, which caused:

  • 1.      Initial Hyperacute Flexion Injury: The rapid deployment of the AHR forced the Plaintiff’s neck into sudden, excessive flexion, worsening pre-existing cervical degeneration and triggering severe radicular symptoms.

  • 2.      Fight-or-Flight Exacerbation: The startling nature of the event caused the Plaintiff to react instinctively in self-defense, twisting violently and further aggravating cervical instability, which contributed to the progression of spinal and neurological damage.

  • These injuries are corroborated by:

  • ·         Comparative imaging across August 2023 (pre-incident), April 2024 (post-surgical), and November 2024 (post-incident progression).

  • ·         The professional opinion of Dr. Simpson, the Plaintiff's neurosurgeon, who identified a causal relationship between the trauma and the escalation of symptoms.

  • As detailed in Dr. Simpson's July 2024 letter (Exhibit A), the post-surgical CT findings (Exhibit B), and the November 2024 cervical MRI (Exhibit C), the AHR deployment caused a rapid worsening of the Plaintiff's condition. These documents collectively establish the Defendants' liability for the Plaintiff's injuries under Arizona law.

  •  

  • Defective Design
    The AHR system was unreasonably dangerous due to its spring-loaded deployment mechanism, which posed a risk of unintended activation. Safer, feasible alternatives, such as a permanently extended headrest design, existed at the time of manufacture, and would have eliminated this risk while simplifying manufacturing.

  • Count 2: Negligence

  • Negligent Design and Omission

  • Defendants breached their duty to design a safe product by opting for an AHR mechanism prone to unintentional deployment. Expert testimony in Costa v. FCA U.S. LLC indicates that FCA was aware of the startle and distraction risks associated with AHR deployment, yet failed to implement safer, cost-effective designs like a permanently extended headrest or to adequately warn consumers of the associated dangers. This breach in duty was a direct cause of Plaintiff’s physical and psychological injuries.

  • Defendants failed to fulfill their duty to adequately warn users of the AHR system’s risks, including the potential for sudden and unexpected deployment. The absence of clear labeling or warnings identifying the AHR as an "active" device contributed to Plaintiff’s injuries. Without any indication that a spring-loaded, rapidly deploying mechanism was situated directly behind his head, Plaintiff was startled by the sudden noise and impact of the device's deployment. This unexpected event caused Plaintiff to perceive an imminent attack, triggering a fight-or-flight response that resulted in PTSD and associated psychological harm.

  • Defendants’ omission of adequate warnings, despite their own owner’s manuals acknowledging the potential for accidental deployment and injury, directly contributed to Plaintiff’s injuries. This failure to warn or label violated Defendants’ duty of care, causing both physical and psychological harm to Plaintiff.

  •      Failure to Act in Good Faith

  • As part of their duty to exercise reasonable care and mitigate harm caused by their defective product, Defendant FCA US LLC had an opportunity to alleviate the Plaintiff’s suffering by providing financial assistance for alternative medical treatments. These treatments were urgently needed to address injuries directly caused by the defective Active Head Restraint (AHR) system.

  • Despite the Plaintiff’s explicit request for assistance and the Defendant’s acknowledgment of the defect and the severity of the injuries, FCA US LLC refused to act in good faith. Instead, the Defendant offered a nominal $2,500 “donation,” an amount insufficient to address even basic medical needs, which the Plaintiff reasonably declined. This refusal delayed necessary care, worsened the Plaintiff’s condition, and caused further physical, emotional, and financial harm.

  • The Defendant’s inaction in the face of clear opportunities to mitigate damages demonstrates a breach of their duty of care and highlights their prioritization of minimizing liability over addressing foreseeable harm caused by their defective product.

  •  



  • Count 3: Unfair or Deceptive Trade Practices

  • Unfair or Deceptive Conduct by FCA
    FCA’s conduct in designing, manufacturing, and marketing the Active Head Restraint (AHR) system constitutes unfair or deceptive practices. Defendants failed to disclose known risks associated with the AHR system’s spring-loaded mechanism, including its tendency for unintentional deployment and the injuries caused by such incidents. This omission misled consumers into believing the AHR system was safe for routine use, despite FCA’s internal knowledge of defects and warranty claims dating back over a decade.

  • Refusal to Provide Meaningful Remedies

  • Defendant FCA US LLC engaged in unfair and deceptive practices by refusing to provide meaningful assistance for medical treatments urgently needed by the Plaintiff. Despite acknowledging the defect in their Active Head Restraint (AHR) system and the injuries caused by its deployment, FCA US LLC offered a nominal $2,500 “donation” rather than a legitimate remedy for the Plaintiff’s medical needs.

  • This offer was framed as a gesture of sympathy, but it was insufficient to cover even basic treatment costs and failed to address the Plaintiff’s suffering. By offering an inadequate remedy while fully aware of the severity of the injuries, FCA misrepresented their willingness to take responsibility for the harm caused by their defective product.

  • Furthermore, the Defendant’s conduct reflects a broader strategy to minimize liability and avoid accountability, as evidenced by their refusal to settle in good faith despite their knowledge of the Plaintiff’s inability to afford alternative treatments. This pattern of behavior constitutes an unfair trade practice, as it deprives injured consumers of the support necessary to mitigate damages and recover from harm directly caused by the Defendant’s defective product.

  •  

  •  Contradictory and Misleading Statements in Manuals
    FCA claimed and still claims to the effect “virtually zero chance of harm” from the AHR system, yet their owner’s manuals include warnings that body parts, such as a hand, could trigger accidental deployment and injury. These manuals failed to distinguish the AHR from standard headrests or provide sufficient guidance to ensure safe handling. This contradictory messaging created confusion among consumers and downplayed the risks associated with routine adjustments or contact with the device. The absence of clear labeling or warnings identifying the AHR system as an active, spring-loaded mechanism constitutes a deceptive omission that misled consumers, including Plaintiff, about the nature and risks of the device. This omission directly contributed to Plaintiff’s misunderstanding of the AHR system’s potential for sudden deployment.  Moreover, Defendants’ public claims as well verbal statement to Plantiff simultaneously claim that the AHR system poses to the effect there is virtually zero chance of harm while warning that accidental contact with the device could result in injury. This contradictory messaging demonstrates Defendants’ awareness of the risks but their failure to adequately disclose them to consumers. By failing to provide clear labeling or warnings, Defendants engaged in deceptive practices that caused Plaintiff to suffer physical injuries and psychological harm.

  • Failure to Warn
    FCA’s omission of explicit warnings about the dangers of excessive force when adjusting the AHR or the likelihood of accidental deployment constitutes a failure to disclose material information necessary for safe use. By failing to adequately inform consumers, FCA deprived them of critical information necessary for making informed safety decisions. .

  • Violation of Consumer Protection Laws
    Defendants’ conduct violates the Arizona Consumer Fraud Act (A.R.S. § 44-1522), which prohibits deceptive acts or practices in connection with the sale or advertisement of merchandise. FCA’s misleading statements, omissions, and failure to warn about the risks of the AHR system represent deceptive practices that caused harm to Plaintiff and other consumers.

  • By failing to provide adequate warnings or distinguish the AHR from standard headrests, FCA’s omissions misled consumers about the true risks of the system. These deceptive practices violate R.S. § 44-1522, which prohibits such omissions in the marketing and sale of consumer products.

  • VI. Prayer for Relief

  •     WHEREFORE, Plaintiff requests judgment against Defendants as follows:

  • a. For general and special damages in an amount to be proven at trial;

  • b. For current and future medical expenses, costs of care, and compensation for emotional and psychological harm, including PTSD, anxiety, and depression caused by the incident and its aftermath;

  • c. For pain and suffering damages, including loss of enjoyment of life, such as the inability to engage in meaningful activities like playing the guitar, artistic self expressive activities or participating fully in professional and personal pursuits;

  • d. For any other relief the Court deems just and proper;

  • e. For punitive damages to the extent permitted by law, as a result of Defendants’ repeated disregard for consumer safety, including their pattern of unfair acts or practices as demonstrated in Costa v. FCA and their ongoing criminal probation;

  • f. For damages and penalties as allowed under the Arizona Consumer Fraud Act for Defendants’ unfair and deceptive trade practices;

  • g. For damages related to Plaintiff’s economic losses, including the inability to pursue business ventures within Arizona’s state-regulated cannabis industry, caused by Defendants’ defective product and failure to warn;

  • h. Injunctive Relief Related to Consumer Protections:

  • ·         An order requiring Defendants to:

  • o    Establish a consumer assistance program to address ongoing risks and injuries associated with defective AHR systems;

  • o    Provide financial support for independent legal representation of injured parties to balance the resource disparity in pursuing claims;

  • o    Notify all current and subsequent vehicle owners of known AHR defects using dealership records;

  • o    Implement mandatory labeling and guidance for AHR systems similar to SRS airbag warnings;

  • o    Provide consumers with updated safety instructions explicitly addressing risks of random deployment.

  • i. An order recommending that the Arizona Attorney General investigate Defendants’ practices and provide support to Arizona residents who, like the Plaintiff, face significant challenges in securing legal representation and pursuing justice against large corporations with substantial legal resources;

  • j. For damages related to emotional distress and psychological harm exacerbated by Defendants’ conduct, including the Plaintiff’s inability to celebrate Christmas with his family due to financial and emotional hardship caused by the defective AHR system and Defendants’ dismissive response;

  • k. An order requiring Defendants to implement consumer notification programs to ensure all vehicle owners are informed about known AHR defects and the availability of safer replacement options;

  • l. For compensation for the necessity of a three-level anterior cervical discectomy and fusion (ACDF) and associated medical treatments, as required due to the trauma caused by the AHR deployment;

  • m. For financial damages related to the Plaintiff’s loss of ability to manage pre-existing lumbar and cervical conditions due to the aggravation and progression caused by the AHR deployment, leading to additional medical costs, physical pain, and emotional suffering;

  • n. For declaratory relief establishing that the Defendants’ failure to warn and defective design of the AHR system constitute violations of Arizona law, requiring immediate corrective measures to prevent further harm to consumers;

  • O. For future monitoring costs for medical conditions related to the injuries caused by the defective AHR system, including but not limited to neurological assessments, spinal imaging, and ongoing pain management.

  • P. For punitive damages:

  • For punitive damages to the extent permitted by law, as a result of Defendant FCA US LLC’s disregard for consumer safety and their failure to provide financial assistance for necessary treatments after acknowledging the defect and the Plaintiff’s injuries.

  • Q. For injunctive relief related to consumer assistance programs:

  • For an order requiring Defendants to establish a consumer assistance program to address ongoing risks and injuries associated with defective AHR systems. This program should include financial support for alternative medical treatments and legal assistance for injured parties to balance the disparity in resources when pursuing claims.

  •  

  •  

  •  

  •      ADDENDA TO COMPLAINT

  •      ADDENDUM A: JUSTIFICATION FOR JURISDICTION AND VENUE IN  STATE COURT

  •      Local Connection to the Claims
    This case arises from injuries sustained by Plaintiff in , where the defective product was in use. Plaintiff is a resident of , and the economic and medical consequences of the injuries have primarily affected Arizona-based systems, including the state Medicaid program.

  •      Economic Impact Specific to
    Plaintiff’s injuries directly impaired his ability to complete a significant business venture under ’s state-regulated medical cannabis framework. This venture was governed by  law and required Plaintiff’s active participation as a licensed professional within the state.  state courts are best positioned to assess the regulatory, economic, and legal impacts of these losses. FCA’s longstanding unfair practices, as evidenced in Costa v. FCA, disproportionately impact  residents who rely on the state’s Medicaid system for medical treatments caused by defective AHR systems. Moreover, the challenges faced by consumers, including Plaintiff, in pursuing legal action underscore the necessity of  courts to ensure accountability and equitable remedies.

  •      Judicial Efficiency and State Interest
     courts have a vested interest in adjudicating claims related to product safety and consumer protection for its residents. Resolving this matter in  state court ensures consistency with similar claims and promotes judicial efficiency by keeping cases with substantial local ties within the state judiciary.

  •      Specialized Considerations for Local Jurors
     residents are directly impacted by the safety and reliability of products sold in their state. Jurors drawn from the local population have a vested interest in addressing public safety issues affecting  consumers.  courts, therefore, represent the most appropriate forum for adjudicating these claims.

  •      Avoidance of Federal Court Challenges Related to Cannabis
    Plaintiff’s economic losses are tied to his role in ’s cannabis industry, which operates under state law. Federal court, bound by federal prohibitions on marijuana, may not fully appreciate or address the intricacies of Plaintiff’s losses under ’s legal framework. Retaining jurisdiction in  state court avoids potential conflicts of law or misinterpretation of state-specific regulatory impacts.

  •      Corporate Misconduct with  Implications:
    FCA’s history of unfair practices, as demonstrated in Costa v. FCA, and their current criminal probation reflect a systemic pattern of conduct that places  consumers at significant risk.  courts are well-positioned to address these state-specific impacts and ensure accountability.

  •      ADDENDUM B: Eggshell Skull Doctrine in

  •      Under  law, the eggshell skull doctrine ensures that a defendant is fully liable for a plaintiff’s injuries from worsening or aggravation, even if the plaintiff had pre-existing conditions that made them more susceptible to harm. In this case, the Plaintiff’s pre-existing degenerative disc disease and congenital spinal stenosis were significantly aggravated by the AHR deployment, causing severe and lasting injuries. These injuries are compensable in full under ’s legal standards, as the Defendant’s defective product caused the harm, regardless of the Plaintiff’s vulnerability.

  •      ADDENDUM C: Consumer Challenges and FCA’s Unfair Practices
    The Plaintiff’s inability to secure legal representation highlights the barriers faced by individuals pursuing claims against FCA Chrysler, given the high litigation costs and the corporation’s extensive resources. This disparity creates systemic inequities that are compounded by FCA’s pattern of unfair practices, as demonstrated in Costa v. FC Despite being found guilty of engaging in unfair acts, FCA continues to employ practices that mislead consumers and evade responsibility for foreseeable safety risks. Addressing these systemic issues is essential to ensuring consumer protection and corporate accountability in .

  •      ADDENDUM D:  of Plaintiff’s Claim from Class Actions

  •      While the Plaintiff is aware of class action lawsuits, including D’Antoni v. FCA US LLC, seeking to encompass claims related to the defective Active Head Restraint (AHR) system, Plaintiff respectfully asserts that this claim warrants separate consideration. The injuries sustained by the Plaintiff are distinct in their severity, including but not limited to a traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), and the necessity of a three-level cervical fusion as well aggravation to lumbar spine condition. These injuries and the resulting economic damages exceed the scope and typical recoveries anticipated in class action settlements.

  •      Class actions serve to address systemic issues but often fail to fully account for claimants with extraordinary injuries. Plaintiff’s claim, which involves profound physical, psychological, and economic harm, requires individualized adjudication to ensure full and fair compensation. Consolidating this matter into a class action would not adequately address the Plaintiff’s unique circumstances, nor provide the equitable remedies needed to redress the significant damages caused by Defendants’ negligence.

  •      Furthermore, Plaintiff’s claim underscores distinct public policy and consumer protection concerns specific to residents, including the impact on state Medicaid resources and the economic harm tied to ’s cannabis industry. For these reasons, Plaintiff respectfully requests that this Court allow the claim to proceed independently and adjudicate it based on its specific merits.

  •  

  •  

  •      Dated this [Date] day of [Month], [Year].

  •      Respectfully submitted,

  •     

  • [ Signature (if filing by hand)]


  • Emory  Caudill